Pfizer is currently at a critical inflection point following its pandemic-era surge. Despite its massive scale and scientific foundation, the... Read more
Tag: #Global Trends
Clinical trial highlights tolerability advantages of protein-based vaccine
A recently published Phase 4 head-to-head trial has evaluated the tolerability of Sanofi’s Nuvaxovid (recombinant protein technology) against Moderna’s mNexspike... Read more
Corporate profile and investigation updates on HiPP baby food contamination
The recall of HiPP baby food products over suspected rodenticide contamination is putting significant pressure on the management and reputation... Read more
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
At the American Association for Cancer Research (AACR) Annual Meeting 2026, Abbott presented new data demonstrating significant advancements in its... Read more
SK Life Science Labs to present new preclinical data on targeted protein degradation at AACR 2026
At the American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego, SK Life Science Labs, a subsidiary... Read more
MSN Laboratories launches Semabest Semaglutide in India to enhance affordability
MSN Laboratories has officially introduced Semabest, its domestic semaglutide brand, to the Indian market following approval from the Central Drugs... Read more
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Partner to Advance ADC Manufacturing
Piramal Pharma Solutions (India) and Ajinomoto Bio-Pharma Services (Japan) have announced a strategic collaboration to enhance the development and manufacturing... Read more
European Commission approves Merck’s ENFLONSIA™ (clesrovimab) for infant RSV prevention
The European Commission (EC) has officially granted marketing authorization for ENFLONSIA™ (clesrovimab), a long-acting monoclonal antibody developed by Merck (MSD)... Read more
Bayer’s FXIa inhibitor asundexian reduces ischemic stroke risk without increasing major bleeding
Bayer has announced the publication of full results from the Phase III OCEANIC-STROKE study in The New England Journal of... Read more









